_id
6919e58b3c536f8df231811f
Ticker
BVXP.LSE
Name
Bioventix
Exchange
LSE
Address
7 Romans Business Park, Farnham, United Kingdom, GU9 7SX
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://www.bioventix.com
Description
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. The company also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
Last Close
18000000
Volume
4127
Current Price
1855
Change
2.7777777777777777
Last Updated
2025-12-29T15:06:38.163Z
Image
https://logo.clearbit.com/www.bioventix.com
Ipo Date
-
Market Cap
94047480
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
6383514
Cost Of Revenue
473274
Gross Profit
5910240
Operating Expenses
988992
Operating Income
4921248
Interest Expense
-
Pretax Income
4912204
Net Income
3812040
Eps
0.7207496776796641
Dividends Per Share
3653759
Shares Outstanding
5224860
Income Tax Expense
1100164
EBITDA
4951369
Operating Margin
77.09308697372639
Total Other Income Expense Net
-9044
Cash
5079295
Short Term Investments
-
Receivables
6243535
Inventories
689404
Total Current Assets
12032679
Property Plant Equipment
404357
Total Assets
12863769
Payables
77948
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1312052
Equity
11551717
Bs_currency_symbol
GBP
Depreciation
39165
Change In Working Capital
-158424
Cash From Operations
3520437
Capital Expenditures
3
Cash From Investing
-
Cash From Financing
-3583505
Net Change In Cash
-63068
Cf_currency_symbol
-
PE
12.5874
PB
849.3180723696746
ROE
32.99976964463378
ROA
29.633927661480865
FCF
3520434
Fcf Percent
0.5514884121817545
Piotroski FScore
3
Health Score
85
Deep Value Investing Score
6.5
Defensive Investing Score
8.5
Dividend Investing Score
3.5
Economic Moat Investing Score
10
Garp Investing Score
6
Growth Investing Score
4.5
Momentum Investing Score
5
Net Net Investing Score
4
Quality Investing Score
10
Value Investing Score
9
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
6383514
Quarters > 0 > income Statement > cost Of Revenue
473274
Quarters > 0 > income Statement > gross Profit
5910240
Quarters > 0 > income Statement > operating Expenses
988992
Quarters > 0 > income Statement > operating Income
4921248
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
4912204
Quarters > 0 > income Statement > net Income
3812040
Quarters > 0 > income Statement > eps
0.7207496776796641
Quarters > 0 > income Statement > dividends Per Share
3653759
Quarters > 0 > income Statement > shares Outstanding
5288993
Quarters > 0 > income Statement > income Tax Expense
1100164
Quarters > 0 > income Statement > EBITDA
4951369
Quarters > 0 > income Statement > operating Margin
77.09308697372639
Quarters > 0 > income Statement > total Other Income Expense Net
-9044
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
5079295
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
6243535
Quarters > 0 > balance Sheet > inventories
689404
Quarters > 0 > balance Sheet > total Current Assets
12032679
Quarters > 0 > balance Sheet > property Plant Equipment
404357
Quarters > 0 > balance Sheet > total Assets
12863769
Quarters > 0 > balance Sheet > payables
77948
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1312052
Quarters > 0 > balance Sheet > equity
11551717
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
3812040
Quarters > 0 > cash Flow > depreciation
39165
Quarters > 0 > cash Flow > change In Working Capital
-158424
Quarters > 0 > cash Flow > cash From Operations
3520437
Quarters > 0 > cash Flow > capital Expenditures
3
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-3583505
Quarters > 0 > cash Flow > net Change In Cash
-63068
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.7207496776796641
Quarters > 0 > ratios > PB
849.3180723696746
Quarters > 0 > ratios > ROE
32.99976964463378
Quarters > 0 > ratios > ROA
29.633927661480865
Quarters > 0 > ratios > FCF
3520434
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.5514884121817545
Quarters > 0 > health Score
85
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
6732355
Quarters > 1 > income Statement > cost Of Revenue
818432
Quarters > 1 > income Statement > gross Profit
5913923
Quarters > 1 > income Statement > operating Expenses
1058848
Quarters > 1 > income Statement > operating Income
4855075
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
4886462
Quarters > 1 > income Statement > net Income
3772402
Quarters > 1 > income Statement > eps
0.7122000729115476
Quarters > 1 > income Statement > dividends Per Share
4541101
Quarters > 1 > income Statement > shares Outstanding
5296829
Quarters > 1 > income Statement > income Tax Expense
1114060
Quarters > 1 > income Statement > EBITDA
4940122
Quarters > 1 > income Statement > operating Margin
72.11555243298965
Quarters > 1 > income Statement > total Other Income Expense Net
31387
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
5142363
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
6443184
Quarters > 1 > balance Sheet > inventories
554069
Quarters > 1 > balance Sheet > total Current Assets
12139616
Quarters > 1 > balance Sheet > property Plant Equipment
443522
Quarters > 1 > balance Sheet > total Assets
13009871
Quarters > 1 > balance Sheet > payables
1731178
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1731178
Quarters > 1 > balance Sheet > equity
11278693
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
3772402
Quarters > 1 > cash Flow > depreciation
53664
Quarters > 1 > cash Flow > change In Working Capital
-47871
Quarters > 1 > cash Flow > cash From Operations
3703700
Quarters > 1 > cash Flow > capital Expenditures
19190
Quarters > 1 > cash Flow > cash From Investing
-19188
Quarters > 1 > cash Flow > cash From Financing
-4541101
Quarters > 1 > cash Flow > net Change In Cash
-856590
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.7122000729115476
Quarters > 1 > ratios > PB
871.1663483525972
Quarters > 1 > ratios > ROE
33.4471556234397
Quarters > 1 > ratios > ROA
28.996459688185993
Quarters > 1 > ratios > FCF
3684510
Quarters > 1 > ratios > Piotroski FScore
3
Quarters > 1 > ratios > fcf Percent
0.5472839741813972
Quarters > 1 > health Score
85
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
6931188
Quarters > 2 > income Statement > cost Of Revenue
527700
Quarters > 2 > income Statement > gross Profit
6403488
Quarters > 2 > income Statement > operating Expenses
951927
Quarters > 2 > income Statement > operating Income
5451561
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
5378090
Quarters > 2 > income Statement > net Income
4073101
Quarters > 2 > income Statement > eps
0.7802999549609697
Quarters > 2 > income Statement > dividends Per Share
3549365
Quarters > 2 > income Statement > shares Outstanding
5219917
Quarters > 2 > income Statement > income Tax Expense
1304988
Quarters > 2 > income Statement > EBITDA
5404118
Quarters > 2 > income Statement > operating Margin
78.65262058971709
Quarters > 2 > income Statement > total Other Income Expense Net
-73471
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
5998953
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
6209430
Quarters > 2 > balance Sheet > inventories
615345
Quarters > 2 > balance Sheet > total Current Assets
12826217
Quarters > 2 > balance Sheet > property Plant Equipment
477997
Quarters > 2 > balance Sheet > total Assets
13730947
Quarters > 2 > balance Sheet > payables
169982
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1728289
Quarters > 2 > balance Sheet > equity
12002658
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
4073101
Quarters > 2 > cash Flow > depreciation
55261
Quarters > 2 > cash Flow > change In Working Capital
-283571
Quarters > 2 > cash Flow > cash From Operations
4053547
Quarters > 2 > cash Flow > capital Expenditures
10587
Quarters > 2 > cash Flow > cash From Investing
-10586
Quarters > 2 > cash Flow > cash From Financing
-3549365
Quarters > 2 > cash Flow > net Change In Cash
493596
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.7802999549609697
Quarters > 2 > ratios > PB
806.7334781179302
Quarters > 2 > ratios > ROE
33.93499173266455
Quarters > 2 > ratios > ROA
29.66365684755756
Quarters > 2 > ratios > FCF
4042960
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.5832997171624835
Quarters > 2 > health Score
85
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
6675396
Quarters > 3 > income Statement > cost Of Revenue
453088
Quarters > 3 > income Statement > gross Profit
6222308
Quarters > 3 > income Statement > operating Expenses
1076271
Quarters > 3 > income Statement > operating Income
5146037
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
5238167
Quarters > 3 > income Statement > net Income
4023615
Quarters > 3 > income Statement > eps
0.7595998806120953
Quarters > 3 > income Statement > dividends Per Share
4697691
Quarters > 3 > income Statement > shares Outstanding
5297019
Quarters > 3 > income Statement > income Tax Expense
1214551
Quarters > 3 > income Statement > EBITDA
5217365
Quarters > 3 > income Statement > operating Margin
77.08961385961223
Quarters > 3 > income Statement > total Other Income Expense Net
92130
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
5505357
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
5924735
Quarters > 3 > balance Sheet > inventories
585735
Quarters > 3 > balance Sheet > total Current Assets
12015827
Quarters > 3 > balance Sheet > property Plant Equipment
522672
Quarters > 3 > balance Sheet > total Assets
13148538
Quarters > 3 > balance Sheet > payables
1707370
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1714105
Quarters > 3 > balance Sheet > equity
11434433
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
4023615
Quarters > 3 > cash Flow > depreciation
58375
Quarters > 3 > cash Flow > change In Working Capital
-78059
Quarters > 3 > cash Flow > cash From Operations
4492550
Quarters > 3 > cash Flow > capital Expenditures
5321
Quarters > 3 > cash Flow > cash From Investing
-5321
Quarters > 3 > cash Flow > cash From Financing
-4697691
Quarters > 3 > cash Flow > net Change In Cash
-210462
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.7595998806120953
Quarters > 3 > ratios > PB
859.3316559727972
Quarters > 3 > ratios > ROE
35.18858346539789
Quarters > 3 > ratios > ROA
30.601234905356016
Quarters > 3 > ratios > FCF
4487229
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.6722041658652161
Quarters > 3 > health Score
86
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
13115869
Annuals > 0 > income Statement > cost Of Revenue
1198877
Annuals > 0 > income Statement > gross Profit
11916992
Annuals > 0 > income Statement > operating Expenses
2013426
Annuals > 0 > income Statement > operating Income
9903566
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
10095915
Annuals > 0 > income Statement > net Income
7584442
Annuals > 0 > income Statement > eps
1.4329496486606177
Annuals > 0 > income Statement > dividends Per Share
8194860
Annuals > 0 > income Statement > shares Outstanding
5292888
Annuals > 0 > income Statement > income Tax Expense
2511473
Annuals > 0 > income Statement > EBITDA
10166401
Annuals > 0 > income Statement > operating Margin
75.50827169743766
Annuals > 0 > income Statement > total Other Income Expense Net
192349
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
5079295
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
6243535
Annuals > 0 > balance Sheet > inventories
689404
Annuals > 0 > balance Sheet > total Current Assets
12032679
Annuals > 0 > balance Sheet > property Plant Equipment
404357
Annuals > 0 > balance Sheet > total Assets
12863769
Annuals > 0 > balance Sheet > payables
77948
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1312052
Annuals > 0 > balance Sheet > equity
11551717
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
7584442
Annuals > 0 > cash Flow > depreciation
92829
Annuals > 0 > cash Flow > change In Working Capital
-206295
Annuals > 0 > cash Flow > cash From Operations
7031788
Annuals > 0 > cash Flow > capital Expenditures
19189
Annuals > 0 > cash Flow > cash From Investing
173160
Annuals > 0 > cash Flow > cash From Financing
-8124606
Annuals > 0 > cash Flow > net Change In Cash
-919658
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
1.4329496486606177
Annuals > 0 > ratios > PB
843.0706811809881
Annuals > 0 > ratios > ROE
65.65640415186765
Annuals > 0 > ratios > ROA
58.959718570816996
Annuals > 0 > ratios > FCF
7012599
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.534665221191215
Annuals > 0 > health Score
85
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
13606584
Annuals > 1 > income Statement > cost Of Revenue
925527
Annuals > 1 > income Statement > gross Profit
12681057
Annuals > 1 > income Statement > operating Expenses
2096864
Annuals > 1 > income Statement > operating Income
10597143
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
10573619
Annuals > 1 > income Statement > net Income
8096717
Annuals > 1 > income Statement > eps
1.5285658485271771
Annuals > 1 > income Statement > dividends Per Share
8247056
Annuals > 1 > income Statement > shares Outstanding
5296937
Annuals > 1 > income Statement > income Tax Expense
2476901
Annuals > 1 > income Statement > EBITDA
10740009
Annuals > 1 > income Statement > operating Margin
77.8824648420206
Annuals > 1 > income Statement > total Other Income Expense Net
18656
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
5998953
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
6209430
Annuals > 1 > balance Sheet > inventories
615345
Annuals > 1 > balance Sheet > total Current Assets
12826217
Annuals > 1 > balance Sheet > property Plant Equipment
477997
Annuals > 1 > balance Sheet > total Assets
13730947
Annuals > 1 > balance Sheet > payables
169982
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1728289
Annuals > 1 > balance Sheet > equity
12002658
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
8096717
Annuals > 1 > cash Flow > depreciation
113636
Annuals > 1 > cash Flow > change In Working Capital
-361630
Annuals > 1 > cash Flow > cash From Operations
8344135
Annuals > 1 > cash Flow > capital Expenditures
15907
Annuals > 1 > cash Flow > cash From Investing
186055
Annuals > 1 > cash Flow > cash From Financing
-8247056
Annuals > 1 > cash Flow > net Change In Cash
283134
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
1.5285658485271771
Annuals > 1 > ratios > PB
812.0171448690782
Annuals > 1 > ratios > ROE
67.45769978616403
Annuals > 1 > ratios > ROA
58.9669234030253
Annuals > 1 > ratios > FCF
8328228
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.6120733903527881
Annuals > 1 > health Score
86
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
12816225
Annuals > 2 > income Statement > cost Of Revenue
957637
Annuals > 2 > income Statement > gross Profit
11858588
Annuals > 2 > income Statement > operating Expenses
1813803
Annuals > 2 > income Statement > operating Income
10044780
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
10109200
Annuals > 2 > income Statement > net Income
8372241
Annuals > 2 > income Statement > eps
1.5828035574622257
Annuals > 2 > income Statement > dividends Per Share
8443058
Annuals > 2 > income Statement > shares Outstanding
5289501
Annuals > 2 > income Statement > income Tax Expense
1736959
Annuals > 2 > income Statement > EBITDA
10199255
Annuals > 2 > income Statement > operating Margin
78.37549668486625
Annuals > 2 > income Statement > total Other Income Expense Net
101094
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
5715819
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
5814761
Annuals > 2 > balance Sheet > inventories
565366
Annuals > 2 > balance Sheet > total Current Assets
12095946
Annuals > 2 > balance Sheet > property Plant Equipment
575726
Annuals > 2 > balance Sheet > total Assets
13281711
Annuals > 2 > balance Sheet > payables
77725
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1217938
Annuals > 2 > balance Sheet > equity
12063773
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
8372241
Annuals > 2 > cash Flow > depreciation
129227
Annuals > 2 > cash Flow > change In Working Capital
-782713
Annuals > 2 > cash Flow > cash From Operations
7903450
Annuals > 2 > cash Flow > capital Expenditures
10583
Annuals > 2 > cash Flow > cash From Investing
90511
Annuals > 2 > cash Flow > cash From Financing
-8303698
Annuals > 2 > cash Flow > net Change In Cash
-410831
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
1.5828035574622257
Annuals > 2 > ratios > PB
806.7693117236207
Annuals > 2 > ratios > ROE
69.39985525258142
Annuals > 2 > ratios > ROA
63.03586187050749
Annuals > 2 > ratios > FCF
7892867
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.6158495968976825
Annuals > 2 > health Score
85
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
11719271
Annuals > 3 > income Statement > cost Of Revenue
853838
Annuals > 3 > income Statement > gross Profit
10865433
Annuals > 3 > income Statement > operating Expenses
1706925
Annuals > 3 > income Statement > operating Income
9273524
Annuals > 3 > income Statement > interest Expense
303
Annuals > 3 > income Statement > pretax Income
9255865
Annuals > 3 > income Statement > net Income
7674151
Annuals > 3 > income Statement > eps
1.4590109454087024
Annuals > 3 > income Statement > dividends Per Share
7918186
Annuals > 3 > income Statement > shares Outstanding
5259831
Annuals > 3 > income Statement > income Tax Expense
1603874
Annuals > 3 > income Statement > EBITDA
9421720
Annuals > 3 > income Statement > operating Margin
79.13055342776867
Annuals > 3 > income Statement > total Other Income Expense Net
4501
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
6126650
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
5224717
Annuals > 3 > balance Sheet > inventories
461815
Annuals > 3 > balance Sheet > total Current Assets
11813182
Annuals > 3 > balance Sheet > property Plant Equipment
694370
Annuals > 3 > balance Sheet > total Assets
13117591
Annuals > 3 > balance Sheet > payables
157280
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1296441
Annuals > 3 > balance Sheet > equity
11821150
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
7674151
Annuals > 3 > cash Flow > depreciation
143392
Annuals > 3 > cash Flow > change In Working Capital
-651761
Annuals > 3 > cash Flow > cash From Operations
7561607
Annuals > 3 > cash Flow > capital Expenditures
11756
Annuals > 3 > cash Flow > cash From Investing
-11756
Annuals > 3 > cash Flow > cash From Financing
-7918186
Annuals > 3 > cash Flow > net Change In Cash
-368335
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
1.4590109454087024
Annuals > 3 > ratios > PB
818.7096043955115
Annuals > 3 > ratios > ROE
64.9188192350152
Annuals > 3 > ratios > ROA
58.50274642653518
Annuals > 3 > ratios > FCF
7549851
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.6442253106016578
Annuals > 3 > health Score
85
Valuation > metrics > PE
12.5874
Valuation > metrics > PB
849.3180723696746
Valuation > final Score
50
Valuation > verdict
14105.3% Overvalued
Profitability > metrics > ROE
32.99976964463378
Profitability > metrics > ROA
31.68072546437913
Profitability > metrics > Net Margin
0.5971695213639384
Profitability > final Score
100
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.11358069107821807
Risk > metrics > Interest Coverage
125.65423209498276
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
154.36802740288397
Liquidity > metrics > Quick Ratio
145.52361830964233
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
40
Prev Profitabilities > 0
100
Prev Profitabilities > 1
100
Prev Profitabilities > 2
100
Prev Risks > 0
100
Prev Risks > 1
100
Prev Risks > 2
100
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:00:25.836Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-30
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-10-27
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.72
Earnings History > 1 > eps Estimate
0.78
Earnings History > 1 > eps Difference
-0.06
Earnings History > 1 > surprise Percent
-7.6923
Earnings History > 2 > period
2024-12-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2024-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.71
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.71
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-12-31
Earnings History > 3 > report Date
2023-03-27
Earnings History > 3 > date
2022-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
0.71
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-09-30
Earnings History > 4 > report Date
2022-10-24
Earnings History > 4 > date
2022-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
0.89
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-12-31
Earnings History > 5 > report Date
2022-03-30
Earnings History > 5 > date
2021-12-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
0.57
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-09-30
Earnings History > 6 > report Date
2021-10-18
Earnings History > 6 > date
2021-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
0.69
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-12-31
Earnings History > 7 > report Date
2021-03-29
Earnings History > 7 > date
2020-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
0.59
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0.59
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-09-30
Earnings History > 8 > report Date
2020-10-19
Earnings History > 8 > date
2020-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
0.7
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0.7
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-12-31
Earnings History > 9 > report Date
2020-03-30
Earnings History > 9 > date
2019-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
0.68
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0.68
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-09-30
Earnings History > 10 > report Date
2019-10-21
Earnings History > 10 > date
2019-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
0.6
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0.6
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-12-31
Earnings History > 11 > report Date
2019-03-21
Earnings History > 11 > date
2018-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
0.53
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0.53
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-09-30
Earnings History > 12 > report Date
2018-10-08
Earnings History > 12 > date
2018-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
0.54
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0.54
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2017-12-31
Earnings History > 13 > report Date
2018-03-22
Earnings History > 13 > date
2017-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
0.54
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0.54
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-09-30
Earnings History > 14 > report Date
2017-10-17
Earnings History > 14 > date
2017-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
0.56
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0.56
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2016-12-31
Earnings History > 15 > report Date
2017-03-20
Earnings History > 15 > date
2016-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
GBP
Earnings History > 15 > eps Actual
0.39
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0.39
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2016-09-30
Earnings History > 16 > report Date
2016-10-17
Earnings History > 16 > date
2016-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
GBP
Earnings History > 16 > eps Actual
0.41
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0.41
Earnings History > 16 > surprise Percent
-
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. The company also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
Stock Price
GBp 0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABioventix plc Corporate Update on FTSE AIM 100 Index Kalkine Media
Read more →Showing 2 of 7
(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very High
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Bioventix
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.72
EPS Estimate
0.78
EPS Difference
-0.06
Surprise Percent
-7.6923%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.